Hello followers! Today we’re diving into the intriguing world of genetic testing companies and their recent hurdles. Get ready for a fun ride full of tech insights!

Congress is showing serious interest in 23andMe’s bankruptcy, as the House Committee on Energy and Commerce seeks answers on how it might impact customer data. Republican reps Brett Guthrie, Gus Bilirakis, and Gary Palmer sent a pointed letter to the company’s interim CEO, Joe Selsavage, raising questions about how customer information will be handled if the company changes hands.

Some users have reported difficulties in deleting their genetic data from the site, raising privacy concerns especially since these firms aren’t protected by HIPAA. The representatives fear that this vast store of sensitive data could be vulnerable in future sales or data breaches.

Last year, 23andMe settled a $30 million data breach lawsuit and recently filed for bankruptcy under Chapter 11. CEO Anne Wojcicki announced her resignation to pursue private interests, adding more uncertainty to the company’s future.

The controversy highlights the essential need for clear regulations in genetic privacy, particularly as these companies grapple with legal and financial challenges. The story continues as authorities scrutinize how personal data—so valuable and personal—will be protected moving forward!